Type i Collagen‐Adhesive and ROS‐Scavenging Nanoreactors Enhanced Retinal Ganglion Cell Survival in an Experimental Optic Nerve Crush Model
Type i Collagen‐Adhesive and ROS‐Scavenging Nanoreactors Enhanced Retinal Ganglion Cell Survival in an Experimental Optic Nerve Crush Model
复制标题
DOI：
10.1002/marc.202300389
复制
发表时间：
2023
期刊：
影响因子：
--
通讯作者：
Shutao Guo
中科院分区：
文献类型：
--
作者：
Yuyuan Du;Maoyu Cai;Jingqing Mu;Xingwei Li;Yapeng Song;Xiaoyong Yuan;Xia Hua;Shutao Guo
AbstractTraumatic optic neuropathy (TON) is a severe condition characterized by retinal ganglion cell (RGC) death, often leading to irreversible vision loss, and the death of RGCs is closely associated with oxidative stress. Unfortunately, effective treatment options for TON are lacking. To address this, catalase (CAT) was encapsulated in a tannic acid (TA)/poly(ethylenimine)‐crosslinked hollow nanoreactor (CAT@PTP), which exhibited enhanced anchoring in the retina due to TA–collagen adhesion. The antioxidative activity of both CAT and TA synergistically eliminated reactive oxygen species (ROS) to save RGCs in the retina, thereby treating TON. In vitro experiments demonstrated that the nanoreactors preserve the enzymatic activity of CAT and exhibit high adhesion to type I collagen. The combination of CAT and TA‐based nanoreactors enhanced ROS elimination while maintaining high biocompatibility. In an optic nerve crush rat model, CAT@PTP was effectively anchored to the retina via TA–collagen adhesion after a single vitreous injection, and RGCs were significantly preserved without adverse events. CAT@PTP exhibited a protective effect on retinal function. Given the abundance of collagen that exists in ocular tissues, our findings may contribute to the further application of this multifunctional nanoreactor in ocular diseases to improve therapeutic efficacy and reduce adverse effects.This article is protected by copyright. All rights reserved
